Superworth

Bolt Biotherapeutics market cap BOLT

Share price times shares outstanding: what the whole company sells for, since 2021.

Today, Nov 2, 2026
$12M
Highest close in our data
$691.9M
Sep 2021

Bolt Biotherapeutics is worth $12M at the close on Nov 2, 2026, at $6.24 a share.

That is up 38% over the last year and down 97% over five years.

Its highest close in our data was $691.9M in Sep 2021.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$12M$6.5M$12.8M+17%
2025$10.2M$8.7M$22.5M−48%
2024$19.8M$19.1M$53.4M−53%
2023$42.5M$33.8M$73M−13%
2022$49M$47.8M$147.6M−73%
2021$182.7M$169.6M$691.9Mn/a

Against its peers

Companies in Drug Manufacturers - General nearest Bolt Biotherapeutics' size, closest first, today.

CompanyMarket cap
BOLTBolt Biotherapeutics$12M
ATNMActinium Pharmaceuticals$45M
SPROSpero Therapeutics$60.6M
LFVNLifevantage$73.5M
Peer median$60.6M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Bolt Biotherapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.